StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck loans Payable and Current Portion of Long-Term Debt ($M) ($M)

Postgres DB financial_values

Latest, FY2025
2,589
Period ended Dec 31, 2025
Change on a year earlier
-2.3%
2,649 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLoans Payable and Current Portion of Long-Term Debt ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,589-2.3%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 20242,649+93.1%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 20231,372-29.5%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 20221,946-19.3%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 20212,412-62.5%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 20206,431+78.1%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 20193,610-32.0%Form 10-K (filed 2020-02-26) ↗
FY2018Dec 31, 20185,308+73.6%Form 10-K (filed 2019-02-27) ↗
FY2017Dec 31, 20173,057+438.2%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 2016568-78.0%SEC Filing ↗
FY2015Dec 31, 20152,583-4.5%SEC Filing ↗
FY2014Dec 31, 20142,704-40.2%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 20134,521+4.8%Form 10-K (filed 2014-02-27) ↗
FY2012Dec 31, 20124,315+116.8%Form 10-K (filed 2013-02-28) ↗
FY2011Dec 31, 20111,990-17.1%Form 10-K (filed 2012-02-28) ↗
FY2010Dec 31, 20102,400+74.0%Form 10-K (filed 2011-02-28) ↗

Cite this data

StockData. (2026). Merck Loans Payable and Current Portion of Long-Term Debt ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_std

See every metric in the Merck KPI table. Data updated Oct 26, 2026.